vs
Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and Finwise Bancorp (FINW). Click either name above to swap in a different company.
Adaptive Biotechnologies Corp is the larger business by last-quarter revenue ($70.9M vs $42.7M, roughly 1.7× Finwise Bancorp). Finwise Bancorp runs the higher net margin — 6.4% vs 4.7%, a 1.7% gap on every dollar of revenue. Over the past eight quarters, Finwise Bancorp's revenue compounded faster (47.0% CAGR vs 28.1%).
ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.
Finwise Bancorp is a U.S.-based financial holding company that operates primarily through its community banking subsidiary. It offers a full suite of retail and commercial financial services, including deposit accounts, personal loans, mortgage products, small business financing, and wealth management solutions, serving local retail consumers and small to medium-sized business clients across its regional operating markets.
ADPT vs FINW — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $70.9M | $42.7M |
| Net Profit | $3.4M | $2.7M |
| Gross Margin | 73.6% | — |
| Operating Margin | -27.1% | — |
| Net Margin | 4.7% | 6.4% |
| Revenue YoY | 35.1% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $70.9M | $42.7M | ||
| Q4 25 | $71.7M | $46.9M | ||
| Q3 25 | $94.0M | $36.7M | ||
| Q2 25 | $58.9M | $25.1M | ||
| Q1 25 | $52.4M | $22.1M | ||
| Q4 24 | $47.5M | $21.1M | ||
| Q3 24 | $46.4M | $20.8M | ||
| Q2 24 | $43.2M | $19.8M |
| Q1 26 | $3.4M | $2.7M | ||
| Q4 25 | $-13.6M | $3.9M | ||
| Q3 25 | $9.5M | $4.9M | ||
| Q2 25 | $-25.6M | $4.1M | ||
| Q1 25 | $-29.9M | $3.2M | ||
| Q4 24 | $-33.7M | $2.8M | ||
| Q3 24 | $-32.1M | $3.5M | ||
| Q2 24 | $-46.2M | $3.2M |
| Q1 26 | 73.6% | — | ||
| Q4 25 | 74.6% | — | ||
| Q3 25 | 80.7% | — | ||
| Q2 25 | 69.4% | — | ||
| Q1 25 | 67.6% | — | ||
| Q4 24 | 62.0% | — | ||
| Q3 24 | 64.1% | — | ||
| Q2 24 | 55.3% | — |
| Q1 26 | -27.1% | — | ||
| Q4 25 | -17.8% | 11.7% | ||
| Q3 25 | 10.9% | 17.5% | ||
| Q2 25 | -42.5% | 21.7% | ||
| Q1 25 | -56.4% | 20.1% | ||
| Q4 24 | -71.3% | 17.5% | ||
| Q3 24 | -70.3% | 22.2% | ||
| Q2 24 | -109.6% | 21.1% |
| Q1 26 | 4.7% | 6.4% | ||
| Q4 25 | -18.9% | 8.4% | ||
| Q3 25 | 10.2% | 13.3% | ||
| Q2 25 | -43.5% | 16.3% | ||
| Q1 25 | -56.9% | 14.4% | ||
| Q4 24 | -71.0% | 13.2% | ||
| Q3 24 | -69.1% | 16.6% | ||
| Q2 24 | -107.0% | 16.1% |
| Q1 26 | — | $0.20 | ||
| Q4 25 | $-0.08 | $0.27 | ||
| Q3 25 | $0.06 | $0.34 | ||
| Q2 25 | $-0.17 | $0.29 | ||
| Q1 25 | $-0.20 | $0.23 | ||
| Q4 24 | $-0.22 | $0.19 | ||
| Q3 24 | $-0.22 | $0.25 | ||
| Q2 24 | $-0.31 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $77.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $196.6M |
| Total Assets | $505.9M | $899.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $77.6M | — | ||
| Q4 25 | $70.5M | $163.4M | ||
| Q3 25 | $55.0M | $105.6M | ||
| Q2 25 | $43.2M | $90.1M | ||
| Q1 25 | $50.6M | $120.3M | ||
| Q4 24 | $47.9M | $109.2M | ||
| Q3 24 | $38.1M | $85.8M | ||
| Q2 24 | $59.8M | $89.0M |
| Q1 26 | — | $196.6M | ||
| Q4 25 | $218.8M | $193.2M | ||
| Q3 25 | $204.4M | $187.8M | ||
| Q2 25 | $179.7M | $182.0M | ||
| Q1 25 | $190.4M | $177.4M | ||
| Q4 24 | $202.7M | $173.7M | ||
| Q3 24 | $223.8M | $170.4M | ||
| Q2 24 | $241.6M | $165.8M |
| Q1 26 | $505.9M | $899.4M | ||
| Q4 25 | $512.7M | $977.1M | ||
| Q3 25 | $490.6M | $899.9M | ||
| Q2 25 | $496.6M | $842.5M | ||
| Q1 25 | $510.9M | $804.1M | ||
| Q4 24 | $539.4M | $746.0M | ||
| Q3 24 | $558.5M | $683.0M | ||
| Q2 24 | $584.9M | $617.8M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADPT
Segment breakdown not available.
FINW
| Net Interest Income | $28.1M | 66% |
| Noninterest Income | $14.6M | 34% |
